The Role of Transgenic Livestock in the Treatment of Human Disease
DOI:
https://doi.org/10.62300/cgbtag09Keywords:
Biotechnology, GMO, transgenicAbstract
This paper describes the potential for transgenic livestock to advance the development of new medications for the treatment of human disease. Two techniques discussed in this paper are the predominant methods used to produce transgenic livestock, pronuclear microinjection and somatic cell nuclear transfer (SCNT). The paper offers a brief overview of current production methods and challenges and addresses economic, regulatory, and societal factors that impact the commercialization of products and treatments derived from transgenic animals. An appendix provides an in-depth description of the SCNT methodology.Downloads
Download data is not yet available.
References
Downloads
Published
2007-05-23
Issue
Section
Issue Papers
License
Copyright (c) 2007 Council for Agricultural Science and Technology (CAST)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
License Terms for CC Attribution-NonCommercial 4.0:
License URL: https://creativecommons.org/licenses/by-nc/4.0/
License Terms Statement:
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material
Under the following conditions:
- Attribution — you must give appropriate credit, provide a link to the license, and indicate if changes were made
- NonCommercial — you may not use the material for commercial purposes
No additional restrictions — you may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
How to Cite
Keefer, C. L., Pommer, J., & Robl, J. M. (2007). The Role of Transgenic Livestock in the Treatment of Human Disease. Council for Agricultural Science and Technology (CAST). https://doi.org/10.62300/cgbtag09
